Patent holdings for IPC class A61K 31/437

Total number of patents in this class: 10354

10-year publication summary

581
583
647
645
622
613
652
597
699
572
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Bristol-myers Squibb Company
4850
182
F. Hoffmann-La Roche AG
7947
136
Incyte Corporation
1028
135
Genentech, Inc.
4012
122
Takeda Pharmaceutical Company Limited
2706
122
Novartis AG
10709
113
Janssen Pharmaceutica N.V.
3370
105
Merck Sharp & Dohme LLC
3756
100
Boehringer Ingelheim International GmbH
4648
98
Gilead Sciences, Inc.
2060
91
Merck Patent GmbH
5773
85
The Regents of the University of California
20137
70
Bayer Pharma AG
1054
69
Hoffmann-La Roche Inc.
3484
68
Abbvie Inc.
1802
68
Dana-Farber Cancer Institute, Inc.
2600
65
Pfizer Inc.
3391
63
Plexxikon Inc.
148
59
Galapagos NV
274
57
Taisho Pharmaceutical Co., Ltd.
865
56
Other owners 8490